NHS to end Palantir contract in 2029
Tech Desk
The government has announced that the NHS will conclude its contract with the technology firm Palantir in 2029. The Department of Health and Social Care (DHSC) has decided to extend the agreement for the federated data platform (FDP) for two additional years, opting against triggering a break clause that would have permitted the deal to end next spring.
Advertisement
Health minister James Frith stated that the move is intended to reduce over-dependence on a single supplier and to foster opportunities for UK-based companies to provide essential digital infrastructure. The DHSC plans to invite domestic firms to tender for the work, with Mr Frith noting that the process must command both clinical confidence and public trust.
The decision has met with criticism from various political figures and campaign groups. Labour MP and chair of the Commons science and technology select committee Dame Chi Onwurah expressed that she was "deeply disappointing to hear that it won’t do so" regarding the 2027 break clause, while Liberal Democrat health spokeswoman Helen Morgan labelled the deal "dangerous". Former Labour shadow chancellor John McDonnell accused Palantir of "human rights abuses" and stated his constituents in Hayes and Harlington "expect the contract to be ended".
Concerns regarding the firm, which was co-founded by billionaire Peter Thiel, often centre on its ties to US defence, security and the Israeli military. Amnesty International, which joined campaign group Just Treatment in calling for the contract to be axed, described the announcement as "a victory for healthcare workers, patients and campaigners who refused to give up". Amnesty crisis campaigner Tom Guha added that "‘First, do no harm’ should apply not just to NHS staff, but to the companies the NHS contracts with."
The British Medical Association welcomed the acknowledgement of concerns but voiced frustration over the delay in transitioning to a new provider. Meanwhile, Palantir UK defended its performance, with senior vice-president Tom Watson stating the company is "proud of our work to date to help deliver more operations, speed up discharge and reduce the time patients need to wait to find out if they have cancer."
Advertisement
Questions have also been raised regarding the platform's adoption, as some NHS care trusts have opted not to use the software. NHS England recently removed a statement from its website claiming 137 trusts were benefiting from the FDP after reports indicated that 29 trusts were using it either rarely or never.